Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: COALESENZ INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-07-28 to 2026-08-27
Current total value of award: $549958.78
Description: AWARD A RESEARCH AND DEVELOPMENT SMALL BUSINESS TECHNOLOGY TRANSFER PROGRAM PHASE II ENHANCEMENT AWARD TO COALESENZ, INC FOR PROJECT TITLED, POINT OF CARE BLOOD COAGULOPATHY DIAGNOSIS.